BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 15254968)

  • 1. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells.
    Arikawa T; Omura K; Morita I
    J Cell Physiol; 2004 Sep; 200(3):400-6. PubMed ID: 15254968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.
    Koide M; Murase Y; Yamato K; Noguchi T; Okahashi N; Nishihara T
    Biochem Biophys Res Commun; 1999 May; 259(1):97-102. PubMed ID: 10334922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
    Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
    J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cyclooxygenase-2 by parathyroid hormone in human osteoblasts in culture.
    Maciel FM; Sarrazin P; Morisset S; Lora M; Patry C; Dumais R; de Brum-Fernandes AJ
    J Rheumatol; 1997 Dec; 24(12):2429-35. PubMed ID: 9415654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis.
    Tanaka N; Sato T; Fujita H; Morita I
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):607-12. PubMed ID: 14726416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo.
    Chikazu D; Li X; Kawaguchi H; Sakuma Y; Voznesensky OS; Adams DJ; Xu M; Hoshio K; Katavic V; Herschman HR; Raisz LG; Pilbeam CC
    J Bone Miner Res; 2002 Aug; 17(8):1430-40. PubMed ID: 12162497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclooxygenase 2 in human malignant melanoma.
    Denkert C; Köbel M; Berger S; Siegert A; Leclere A; Trefzer U; Hauptmann S
    Cancer Res; 2001 Jan; 61(1):303-8. PubMed ID: 11196178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.
    Hui AY; Dannenberg AJ; Sung JJ; Subbaramaiah K; Du B; Olinga P; Friedman SL
    J Hepatol; 2004 Aug; 41(2):251-8. PubMed ID: 15288474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic fibroblast growth factor induces cyclooxygenase-2 expression in endothelial cells derived from bone.
    Kage K; Fujita N; Oh-hara T; Ogata E; Fujita T; Tsuruo T
    Biochem Biophys Res Commun; 1999 Jan; 254(1):259-63. PubMed ID: 9920767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prostaglandin E2 on recombinant human bone morphogenetic protein-2-stimulated osteoblastic differentiation in human periodontal ligament cells.
    Takiguchi T; Kobayashi M; Nagashima C; Yamaguchi A; Nishihara T; Hasegawa K
    J Periodontal Res; 1999 Oct; 34(7):431-6. PubMed ID: 10685373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of COX-2 mediates acid-induced bone calcium efflux in vitro.
    Krieger NS; Frick KK; LaPlante Strutz K; Michalenka A; Bushinsky DA
    J Bone Miner Res; 2007 Jun; 22(6):907-17. PubMed ID: 17352658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1beta stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2.
    Watanabe Y; Namba A; Honda K; Aida Y; Matsumura H; Shimizu O; Suzuki N; Tanabe N; Maeno M
    Connect Tissue Res; 2009; 50(3):186-93. PubMed ID: 19444759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells.
    Harizi H; Juzan M; Grosset C; Rashedi M; Gualde N
    Cell Immunol; 2001 Apr; 209(1):19-28. PubMed ID: 11414733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils.
    Kimura T; Iwase M; Kondo G; Watanabe H; Ohashi M; Ito D; Nagumo M
    Int Immunopharmacol; 2003 Oct; 3(10-11):1519-28. PubMed ID: 12946449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells.
    Fehrenbacher JC; Burkey TH; Nicol GD; Vasko MR
    Pain; 2005 Jan; 113(1-2):113-22. PubMed ID: 15621371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
    Xu H; Izon DJ; Loftin C; Spain LM
    Cell Immunol; 2001 Dec; 214(2):184-93. PubMed ID: 12088417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4.
    El-Haroun H; Bradbury D; Clayton A; Knox AJ
    Circ Res; 2004 Feb; 94(3):353-61. PubMed ID: 14670842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.